⌘K

Login Start Free

Home/Filings/4/0001127602-10-007699

4//SEC Filing

Mills Mike 4

Accession 0001127602-10-007699

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 2:43 PM ET

Size

5.4 KB

Accession

0001127602-10-007699

Insider Transaction Report

Form 4

Period: 2010-03-01

BIOCRYST PHARMACEUTICALS INCBCRX

Principal Accounting Officer

Transactions

Award
Emp. Stock Option (Right to Buy)
2010-03-01+15,000→ 15,000 total
Exercise: $6.68Exp: 2020-03-01→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]Options become exercisable at the rate of 25% after 1 year and then 1/48 per month thereafter until fully vested and exercisable after 48 months.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001452496

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 2:43 PM ET
Size: 5.4 KB

View on SEC.gov